Ventripoint Diagnostics Ltd. (TSXV:VPT)
Canada · Delayed Price · Currency is CAD 0.1000
-0.0050 (-4.76%)
Aug 21, 2026, 2:23 PM EST
Ventripoint Diagnostics Revenue
In the year 2025, Ventripoint Diagnostics had annual revenue of 179.93K CAD with 89.06% growth. Ventripoint Diagnostics had revenue of 104.30K in the quarter ending December 31, 2025, with 61.69% growth.
Revenue
179.93K
Revenue Growth
+89.06%
P/S Ratio
108.82
Revenue / Employee
n/a
Employees
n/a
Market Cap
19.58M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 179.93K | 84.76K | 89.06% |
| Dec 31, 2024 | 95.17K | 45.99K | 93.51% |
| Dec 31, 2023 | 49.18K | -18.98K | -27.85% |
| Dec 31, 2022 | 68.17K | - | - |
| Dec 31, 2021 | - | - | - |
| Dec 31, 2020 | 36.02K | -45.01K | -55.55% |
| Dec 31, 2019 | 81.02K | 20.85K | 34.64% |
| Dec 31, 2018 | 60.18K | 21.27K | 54.68% |
| Dec 31, 2017 | 38.91K | -170.57K | -81.43% |
| Dec 31, 2016 | 209.48K | 158.18K | 308.38% |
| Dec 31, 2015 | 51.30K | -77.16K | -60.07% |
| Dec 31, 2014 | 128.45K | 57.51K | 81.05% |
| Dec 31, 2013 | 70.95K | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Aurora Spine | 25.67M |
| Perimeter Medical Imaging AI | 2.98M |
| Cheelcare | 1.63M |
| Theralase Technologies | 857.91K |
| Conavi Medical | 778.00K |
| Frequency Exchange | 745.08K |
| MedX Health | 539.93K |
| NuGen Medical Devices | 165.74K |
Ventripoint Diagnostics News
- 1 day ago - UniDoc Health Signs MOU with Ventripoint Diagnostics to Evaluate Remote Cardiac Assessment and Screening Platform - Accesswire
- 8 days ago - Ventripoint Expands Subscription Access for FDA-Cleared AI Cardiac Imaging - BNN Bloomberg
- 9 days ago - Ventripoint Expands Subscription Access for FDA-Cleared AI Cardiac Imaging - GlobeNewsWire
- 13 days ago - Ventripoint Diagnostics Announces Cancellation and Re-Grant of Options, Grant of Annual Incentive Options and Private Placement - TheNewswire
- 16 days ago - UniDoc Health and Ventripoint Diagnostics Sign MOU to Evaluate Scalable Remote Cardiac Assessment and Screening Platform - TheNewswire
- 22 days ago - Ventripoint Strengthens Board with Appointment of MedTech Executive and Commercialization Leader Dr. Philip Toleikis - TheNewswire
- 4 weeks ago - Ventripoint Issue Shares for Payment of Debenture Interest - TheNewswire
- 4 weeks ago - Ventripoint Engages More Capital Ltd. - TheNewswire